AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AZN Key Statistics
AZN News
Thursday, May 3, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on...
AstraZeneca (AZN) has released an update. AstraZeneca’s Calquence, combined with chemoimmunotherapy, has shown a statistically significant improvement in progr...
Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZeneca’s Calquence in combination with standard-of-care chemoimmuno...
Analyst ratings
74%
of 31 ratingsMore AZN News
Bearish flow noted in AstraZeneca with 6,310 puts trading, or 1.5x expected. Most active are 5/24 weekly 64 puts and Oct-24 77.5 puts, with total volume in thos...
AstraZeneca (AZN) has released an update. AstraZeneca PLC, a leading biopharmaceutical company, announced that as of April 30, 2024, its issued share capital w...
AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.03 EPS, expect...
AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown European pharma giant AstraZeneca...
AstraZeneca (AZN) has released an update. AstraZeneca PLC’s drug Truqap, in combination with Faslodex, has been recommended for EU approval for treating advanc...
In top news on UK stocks, AstraZeneca PLC (GB:AZN) shares are rising today after the company released promising updates on two of its breast cancer drugs, Truqa...
Loading... Loading... AstraZeneca plc AZN reported topline data from a metastatic breast cancer treatment study. The results showed that Enhertu (trastuzumab...
